Brian Armstrong’s Human Life Extension Venture Raises Fresh Cash

Brian Armstrong’s NewLimit, the longevity startup founded by the Coinbase Inc. executive that’s aiming to extend human life through reprogramming human genes, raised a new round of funding that values the company at $810 million.

NewLimit raised $130 million of a Series B round led by Kleiner Perkins, the epigenetics company said in a statement. The valuation was confirmed by a spokesperson.

Brian Armstrong

Photographer: Stefan Wermuth/Bloomberg

Armstrong, the chief executive and co-founder of Coinbase, began NewLimit in 2021 in the wake of his cryptocurrency exchange’s initial public offering, dedicating wealth generated from the listing to an area of technology that he viewed ...